CYP7A1 and metabolic dysfunction-associated steatohepatitis: In NASH mice, increased primary BA production by upregulating CYP7B1 and CYP7A1 make up for the low hepatic exposure to BA, but completely alters the balance between primary and secondary BA secreted by the liver [49].